Clinical Trials Directory

Trials / Completed

CompletedNCT04091841

Trial of Protein Supplement on Vertebral Fusion in Posterior Spine Fusion Surgery

The Effect of Protein Supplement on Vertebral Fusion and Enhanced Recovery After Posterior Spine Fusion Surgery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Shahid Beheshti University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Receiving protein can affect the bone formation and maintenance by providing a structural matrix of the bone, optimizing the level of IGF-1, increasing intestinal calcium absorption, transferring phosphorous, and improving muscle strength.Therefore, protein may be effective on vertebral fusion by such mechanisms. In this trial patients undergoing elective posterior spine fusion surgery are divided into two groups of intervention or control.

Detailed description

A randomized, double blind, controlled trial will be conducted in patients undergoing elective posterior spine fusion surgery in Tehran, Iran. After a full review of the inclusion and exclusion criteria and explanation of the risks and benefits of the study, written consent form will be completed. The participants are 80 eligible posterior spine fusion surgery patients, aged ≥ 18 years. Intervention patients will be received 36 grams of protein supplement along with diet containing 1.2 g/kg/day of protein for 30 days after surgery and control patients will be received Carbo Mass along with diet containing 1.2 g/kg/day of protein 30 days after surgery. Patients will be evaluated for occurrence of vertebral fusion and enhanced recovery after 3 months surgery.

Conditions

Interventions

TypeNameDescription
DRUGprotein supplementThree sachet of protein supplement to be mixed in with water used daily.
OTHERCarbo MassThree sachet of Carbo Mass supplement to be mixed in with water used daily.

Timeline

Start date
2019-08-01
Primary completion
2020-10-01
Completion
2020-10-01
First posted
2019-09-17
Last updated
2020-11-30

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT04091841. Inclusion in this directory is not an endorsement.